发明授权
- 专利标题： Heteroaryl-substituted imidazole compounds and uses thereof
- 专利标题（中）： 杂芳基取代的咪唑化合物及其用途
-
申请号： US12383035申请日： 2009-03-19
-
公开(公告)号： US08129394B2公开(公告)日： 2012-03-06
- 发明人: Zilin Hunag , Jeff Jin , Timothy Machajewski , William R. Antonios-McCrea , Maureen McKenna , Daniel Poon , Paul A. Renhowe , Martin Sendzik , Cynthia Shafer , Aaron Smith , Yongjin Xu , Qiong Zhang , Zheng Chen
- 申请人： Zilin Hunag , Jeff Jin , Timothy Machajewski , William R. Antonios-McCrea , Maureen McKenna , Daniel Poon , Paul A. Renhowe , Martin Sendzik , Cynthia Shafer , Aaron Smith , Yongjin Xu , Qiong Zhang , Zheng Chen
- 申请人地址： CH Basel
- 专利权人： Novartis AG
- 当前专利权人： Novartis AG
- 当前专利权人地址： CH Basel
- 代理商 Michael G. Smith
- 主分类号： A61K31/4965
- IPC分类号： A61K31/4965 ; A61K31/505 ; A01N43/54 ; C07D403/00 ; C07D401/00 ; C07D405/00 ; C07D409/00 ; C07D411/00 ; C07D413/00 ; C07D417/00 ; C07D419/00
摘要：
Novel imidazole compounds of the general formula are disclosed, wherein R1 and R2 comprise heteroaryl groups. These compounds and compositions containing them are useful in methods to treat Raf kinase-mediated disorders such as cancer.
公开/授权文献
- US20100003246A1 Novel heterocyclic compounds and uses therof 公开/授权日：2010-01-07
信息查询
